Have a personal or library account? Click to login
Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology Cover

Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology

Open Access
|Jan 2018

References

  1. 1. J. M. Flack and S. A. Nasser, Benefits of once-daily therapies in the treatment of hypertension, Vasc. Health Risk Manag. 7 (2011) 777-787; https://doi.org/10.2147/VHRM.S17207 10.2147/VHRM.S17207325377122241952
  2. 2. R. Bodmeier, J. Wang and H. Bhagwatwar, Process and formulation variables in the preparation of wax microparticles by melt dispersion technique for water insoluble drugs, J. Microencapsul. 9 (1992) 89-98; https://doi.org/103109/0265204920902122610.3109/026520492090212261613647
  3. 3. R. B. Oliveira, T. L. Nascimento and E. M. Lima, Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles, Drug Dev. Ind. Pharm. 38 (2012) 1-11; https://doi.org/10.3109/03639045.2011.58743310.3109/03639045.2011.58743321671838
  4. 4. C. M. Adeyeye and J. C. Price, Development and evaluation of sustained release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics, Pharm. Res. 8 (1991) 1377-1383; https://doi.org/10.1023/A:101584502211210.1023/A:1015845022112
  5. 5. Y. A. Goma, I. A. Darwish, N. A. Boraei and L. K. El-Khordagui, Formulation of wax oxybenzone microparticles using a factorial approach, J. Microencapsul. 27 (2010) 628-639; https://doi.org/10.3109/02652048.2010.50658010.3109/02652048.2010.50658020681744
  6. 6. L. M. Van Bortel, F. Fici and F. Mascagni, Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis, Am. J. Cardiovasc. Drugs 8 (2008) 35-44; https://doi.org/10.2165/00129784-200808010-0000510.2165/00129784-200808010-0000518303936
  7. 7. L. A. D. Silva, F. V. Teixeira, R. C. Sepra, N. L. Esteves, R. R. Dos-Santos, E. M. Lima, et al., Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems, J. Therm. Anal. Calorim. 123 (2016) 2337-2344; https://doi.org/10.1007/s10973-015-5022-110.1007/s10973-015-5022-1
  8. 8. K. Westesen and B. Siekmann, Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof, U.S. Pat. 08/226, 471, 12 April 1994; Publication date July 28 (1998) 5785976 A.
  9. 9. S. N. Patere, N. S. Desai, A. S. Jain, P. P. Kadam, U. M. Thatta, N. Gogtay, C. J. Kapadia, N. Farah and M. S. Nagarsenker, Compritol® 8 88 ATO, a l ipid e xcipient f or s ustained r elease of h ighly water soluble active formulation, scale-up and IVIVC study, Curr. Drug Deliv. 10 (2013) 548-556; https://doi.org/10.2174/156720181131005000610.2174/156720181131005000623607649
  10. 10. M. K. Shah, P. Madan and S. Lin, Preparation, in vitro evaluation and statistical optimization of carvedilol loaded solid lipid nanoparticles for lymphatic absorption via oral administration, Pharm. Dev. Technol. 19 (2014) 475-485; https://doi.org/10.3109/10837450.2013.79516910.3109/10837450.2013.79516923697916
  11. 11. M. R. Priya and N. Jeevitha, semi-solid dispersion of carvedilol solid lipid nanoparticles for topical delivery, EJPMR 3 (2016) 231-238.
  12. 12. H. M. Aboud, M. H. El Komy, A. A. Ali, S. F. El Menshawe and A. Abdelbary, Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery, AAPS PharmSciTech. 17 (2016) 1353-1365; https://doi.org/10.1208/s12249-015-0440-810.1208/s12249-015-0440-826743643
  13. 13. A. A. Attama, S. Reichl and C. C. Muller-Goymann, Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea, Curr. Eye Res. 34 (2009) 698-705; https://doi.org/10.1080/0271368090301750010.1080/0271368090301750019899997
  14. 14. S. N. Patere, C. J. Kapadia and M. S. Nagarsenker, Influence of formulation factors and compression force on release profile of sustained release Metoprolol tablets using Compritol®888ATO as lipid excipient, Indian J. Pharm. Sci. 77 (2015) 620-625; https://doi.org/10.4103/0250-474X.16903010.4103/0250-474X.169030
  15. 15. A. Bruzzo, T. Cerchiara, F. Bigucci, M. C. Gallucci and B. Luppi, Mucoadhesive buccal tablets based on chitosan/gelatin microparticles for delivery of propranolol hydrochloride, J. Pharm. Sci. 104 (2015) 4365-4372; https://doi.org/10.1002/jps.2468810.1002/jps.2468826505621
  16. 16. S. S. Sule and W. Frishman, Nebivolol: new therapy update, Cardiol Rev. 14 (2006) 2 59-264; https://doi.org/10.1097/01.crd.0000223651.03023.8e10.1097/01.crd.0000223651.03023.8e16924166
  17. 17. W. Chaisri, W. E. Hennink, C. Ampasavate and S. Okonogi, Cephalexin microspheres for dairy mastitis: Effect of preparation method and surfactant type on physicochemical properties of the microspheres, AAPS PharmSciTech. 11 (2010) 945-951; https://doi.org/10.1208/s12249-010-9453-510.1208/s12249-010-9453-5290235120509056
  18. 18. X. Wu, G. Li and Y. Gao, Optimization of the preparation of nalmefene-loaded sustained-release microspheres using central composite design, Chem. Pharm. Bull. 54 (2006) 977-981; https://doi.org/10.1248/cpb.54.97710.1248/cpb.54.97716819215
  19. 19. S. Milak, N. Medlicott and I. G. Tucker, Solid lipid microparticles containing loratadine prepared using a micromixer, J. Microencapsul. 23 (2006) 823-831; https://doi.org/10.1080/0968786060094575010.1080/0968786060094575017390624
  20. 20. B. Albertini, N. Passerini, M. L. Gonzalez-Rodriguez, B. Perissutti and L. Rodriguez, Effect of Aerosil on the properties of lipid controlled release microparticles, J. Control. Release 100 (2004) 233-246; https://doi.org/10.1016/j.jconrel.2004.08.01310.1016/j.jconrel.2004.08.01315544871
  21. 21. S. Mukherjee, S. Ray and R. S. Thakur, Solid lipid nanoparticles: a modern formulation approach in drug delivery system, Indian J. Pharm. Sci. 71 (2009) 349-358; https://doi.org/10.4103/0250-474X.5728210.4103/0250-474X.57282286580520502539
  22. 22. J. Hao, X. Fang, Y. Zhou, J. Wang, F. Guo, F. Li and X. Peng, Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design, Int. J. Nanomedicine. 6 (2011) 683-692; https://doi.org/10.2147/IJN.S1738610.2147/IJN.S17386308431521556343
  23. 23. C. Narendra, M. S. Srinath and R. Prakash, Development of a three layered buccal compact containing metoprolol tartrate by statistical optimization technique, Int. J. Pharm. 304 (2005) 102-114; https://doi.org/10.1016/j.ijpharm.2005.07.02110.1016/j.ijpharm.2005.07.02116150561
  24. 24. B. C. Nandy and B. Mazumder, Formulation and characterizations of delayed release multi-particulates system of indomethacin: optimization by response surface methodology, Curr. Drug Deliv. 10 (2014) 72-86; https://doi.org/10.2174/15672018109990041
  25. 25. D. V. Gowda and H. G. Shivakumar, Preparation and evaluation of waxes/fat microspheres loaded with lithium carbonate for controlled release, Indian J. Pharm. Sci. 69 (2007) 251-256; https://doi.org/10.4103/0250-474X.3315210.4103/0250-474X.33152
  26. 26. S. B. Patil and K. K. Sawant, Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery, J. Microencapsul. 26 (2009) 432-443; https://doi.org/10.1080/0265204080245672610.1080/0265204080245672618932060
  27. 27. L. Capretto, S. Mazzitelli and C. Nastruzzi, Design, production and optimization of solid lipid microparticles (SLM) by a coaxial microfluidic device, J. Control. Release 160 (2012) 409-417; https://doi.org/10.1016/j.jconrel.2012.04.01910.1016/j.jconrel.2012.04.01922542700
  28. 28. D. Jain and R. Banerjee, Comparison of ciprofloxacin hydrochloride-loaded protein, lipid and chitosan nanoparticles for drug delivery, J. Biomed. Mater. Res. B Appl. Biomater. 86 (2008) 105-112; https://doi.org/10.1002/jbm.b.3099410.1002/jbm.b.3099418098198
  29. 29. S. Lacerda, N. Cerize and M. Re, Preparation and characterization of carnauba waxnanostructured lipid carriers containing benzophenone-3, Int. J. Cosmet. Sci. 33 (2011) 312-321; https://doi.org/10.1111/j.1468-2494.2010.00626.x10.1111/j.1468-2494.2010.00626.x21284656
DOI: https://doi.org/10.1515/acph-2017-0034 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 441 - 461
Accepted on: Jul 18, 2017
Published on: Jan 11, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Muhammad Hanif, Hafeez Ullah Khan, Samina Afzal, Asif Mahmood, Safirah Maheen, Khurram Afzal, Nabila Iqbal, Mehwish Andleeb, Nazar Abbas, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.